Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-25-000240
Filing Date
2025-06-18
Accepted
2025-06-18 16:06:09
Documents
1
Period of Report
2025-06-16

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3975
  Complete submission text file 0001610717-25-000240.txt   5384
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Cislini Jeff (Reporting) CIK: 0001969082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39219 | Film No.: 251056940